Israeli digital health fund aMoon II, set up last year by aMoon Partners, has received commitments by investors to receive some $600 million which may become $750 million by February, Reuters reported. This far exceeds the original $500 million target set by the fund.
The fund is founded by Dr. Yair Schindel, its managing partner, and Marius Nacht, the billionaire co-founder of cybersecurity giant CheckPoint Software Technologies. It is focused on investing in mid- to late-stage companies in the health and medical technologies field.
In May, leading financial services company Credit Suisse committed a $250 million investment for aMoon II. The previous month,the fund raised $200 million from private investors.
The average investment by aMoon II in companies will be between $10 million and $40 million, Schindel has previously said, with most of the investments in Israel and with possible opportunities in the US, the UK, and Switzerland.
The first aMoon health fund was set up in 2017, with Nacht putting up $200 million of his own money. The fund invested in 16 startups.
A third fund, aMoon Velocity, will focus on early-stage startups, Reuters reported, and is open only to investors in aMoon II. aMoon Velocity has a fundraising target of $120 million.